Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$438M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$309M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$274M |
| 4 |
PepsiCo
PEP
|
+$229M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$752M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$448M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Healthcare | 5.4% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 4.64% |
| 5 | Industrials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.72B
| $2.71M | ﹤0.01% |
79,400
-183,045
| -70% | -$6.77M |
|
1752
PUT
Emerson Electric
EMR
$81.6B
| $2.7M | ﹤0.01% |
+28,000
| New | +$2.67M |
|
1753
Universal Health Services
UHS
$10.2B
| $2.7M | ﹤0.01% |
21,504
-16,370
| -43% | -$2.23M |
|
1754
PUT
NXP Semiconductors
NXPI
$60.8B
| $2.7M | ﹤0.01% |
+13,500
| New | +$2.79M |
|
1755
Enterprise Products Partners
EPD
$83.7B
| $2.69M | ﹤0.01% |
98,405
+41,822
| +74% | +$1.12M |
|
1756
Revolution Medicines
RVMD
$38.5B
| $2.69M | ﹤0.01% |
97,234
-25,290
| -21% | -$750K |
|
1757
iShares MSCI Global Sustainable Development Goals ETF
SDG
$168M
| $2.69M | ﹤0.01% |
36,056
+3,670
| +11% | +$289K |
|
1758
UiPath
PATH
$6.52B
| $2.68M | ﹤0.01% |
156,635
+55,216
| +54% | +$919K |
|
1759
Globant
GLOB
$1.65B
| $2.67M | ﹤0.01% |
13,492
-2,405
| -15% | -$451K |
|
|
KALV
1760
DELISTED
KalVista Pharmaceuticals
KALV
| $2.67M | ﹤0.01% |
276,918
-22,890
| -8% | -$234K |
|
|
SNV
1761
DELISTED
Synovus
SNV
| $2.66M | ﹤0.01% |
95,707
-59,403
| -38% | -$1.86M |
|
|
ICPT
1762
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.66M | ﹤0.01% |
143,414
-1,017,987
| -88% | -$11.5M |
|
1763
Trex
TREX
$4.4B
| $2.66M | ﹤0.01% |
43,126
-23,362
| -35% | -$1.6M |
|
|
ESGR
1764
DELISTED
Enstar Group
ESGR
| $2.65M | ﹤0.01% |
10,952
-3,968
| -27% | -$995K |
|
1765
GFL Environmental
GFL
$14.5B
| $2.65M | ﹤0.01% |
82,932
-10,640
| -11% | -$365K |
|
1766
Vanguard Long-Term Bond ETF
BLV
$5.74B
| $2.64M | ﹤0.01% |
39,415
-8,612
| -18% | -$614K |
|
1767
Columbia Banking Systems
COLB
$8.71B
| $2.64M | ﹤0.01% |
129,817
-86,008
| -40% | -$1.79M |
|
|
SPNS
1768
DELISTED
Sapiens International
SPNS
| $2.64M | ﹤0.01% |
92,686
-33,065
| -26% | -$946K |
|
1769
BioCryst Pharmaceuticals
BCRX
$2.42B
| $2.63M | ﹤0.01% |
371,872
+19,329
| +5% | +$139K |
|
1770
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
| $2.63M | ﹤0.01% |
144,029
+73,629
| +105% | +$1.41M |
|
1771
Affirm
AFRM
$23.5B
| $2.62M | ﹤0.01% |
123,271
-21,972
| -15% | -$402K |
|
1772
Invesco Variable Rate Preferred ETF
VRP
$2.98B
| $2.62M | ﹤0.01% |
116,941
-50,164
| -30% | -$1.13M |
|
1773
Arcus Biosciences
RCUS
$3.33B
| $2.62M | ﹤0.01% |
145,729
+25,083
| +21% | +$504K |
|
1774
PUT
Vale
VALE
$62.3B
| $2.61M | ﹤0.01% |
+195,000
| New | +$2.65M |
|
1775
The Ensign Group
ENSG
$10.6B
| $2.61M | ﹤0.01% |
28,112
-18,677
| -40% | -$1.77M |
|
Similar funds
Citigroup's Q3 2023 Portfolio in Review
As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.
- Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
- Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
- Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
- Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
- Citigroup opened 337 new positions and closed 265 in Q3 2023.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.